Medcan Australia
PrivateLast Round
Early Funding
Jan 10, 2022
Total Funding Raised
$8M
Company Overview
Medcan Australia operates in Healthcare & Life Sciences and is based in Mount Ommaney. Its latest recorded funding round was a Seed round in November 2019.
Medcan Australia is a pharmaceutical and biotechnology company that cultivates, produces, and manufactures medicinal cannabis products for clinical and individual patient use.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Compliance, Quality Management
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Medcan Australia Comparables
Compare Medcan Australia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Australian Natural Therapeutics Group | 89% | |
| Cymra Life Sciences | 86% | |
| Cann Group Ltd | 86% |
For institutional investors. Book with your work email.
Medcan Australia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jan 10, 2022 | ||||
| Seed | Nov 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 25, 2026
Grew 17% QoQ, from 29 to 34 employees.
- May 17, 2026
Monthly visitors grew 69% MoM, reaching 2.3K.
For institutional investors. Book with your work email.
Medcan Australia Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Medcan Australia's valuation, stock price, and market status.
Is Medcan Australia a public or private company?
Medcan Australia is a private company.
What is the current stock price of Medcan Australia?
Medcan Australia is a private company, so its shares have no public market price. Caplight tracks Medcan Australia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Medcan Australia worth (valuation)?
Valuation information for Medcan Australia is not publicly available.
Can I buy Medcan Australia stock?
Medcan Australia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Medcan Australia's last funding round?
Medcan Australia's most recent funding round was Early Funding on January 10, 2022.
Who are the main investors in Medcan Australia?
Investor information for Medcan Australia is not publicly disclosed.
Will Medcan Australia IPO soon?
No public IPO plans have been announced for Medcan Australia.
How can I track Medcan Australia secondary market activity?
Caplight tracks bids, offers, and trades in Medcan Australia's shares on secondary markets.